169 related articles for article (PubMed ID: 21259237)
41. Analysis of skin disposition of flurbiprofen after topical application using dual agar gel discs-inserted rats.
Hasegawa T; Kawazome A; Yanagimoto G; Hayashi T; Seki T; Akimoto M; Todo H; Sugibayashi K
Biol Pharm Bull; 2007 Nov; 30(11):2135-40. PubMed ID: 17978488
[TBL] [Abstract][Full Text] [Related]
42. Development of ibuprofen nanoliposome for transdermal delivery: Physical characterization, in vitro/in vivo studies, and anti-inflammatory activity.
Gaur PK; Bajpai M; Mishra S; Verma A
Artif Cells Nanomed Biotechnol; 2016; 44(1):370-5. PubMed ID: 25211229
[TBL] [Abstract][Full Text] [Related]
43. Development and optimization of boswellic acid-loaded proniosomal gel.
Mehta M; Dureja H; Garg M
Drug Deliv; 2016 Oct; 23(8):3072-3081. PubMed ID: 26953869
[TBL] [Abstract][Full Text] [Related]
44. Formulation of an aqueous injection of flurbiprofen.
Gupta GD; Jain S; Jain NK
Pharmazie; 1997 Sep; 52(9):709-12. PubMed ID: 9347572
[TBL] [Abstract][Full Text] [Related]
45. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Int J Pharm; 2013 Feb; 443(1-2):26-38. PubMed ID: 23313344
[TBL] [Abstract][Full Text] [Related]
46. Formulation and evaluation of anti-rheumatic dexibuprofen transdermal patches: a quality-by-design approach.
Akhlaq M; Arshad MS; Mudassir AM; Hussain A; Kucuk I; Haj-Ahmad R; Rasekh M; Ahmad Z
J Drug Target; 2016 Aug; 24(7):603-12. PubMed ID: 26586147
[TBL] [Abstract][Full Text] [Related]
47. Does stereochemistry influence transdermal permeation of flurbiprofen through the rat skin?
Valentová J; Bauerová K; Farah L; Devínsky F
Arch Dermatol Res; 2010 Oct; 302(8):635-8. PubMed ID: 20582424
[TBL] [Abstract][Full Text] [Related]
48. Influence of the oral dissolution time on the absorption rate of locally administered solid formulations for oromucosal use: the flurbiprofen lozenges paradigm.
Imberti R; De Gregori S; Lisi L; Navarra P
Pharmacology; 2014; 94(3-4):143-7. PubMed ID: 25277061
[TBL] [Abstract][Full Text] [Related]
49. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain.
Abdelbary GA; Aburahma MH
J Liposome Res; 2015; 25(2):107-21. PubMed ID: 25058447
[TBL] [Abstract][Full Text] [Related]
50. Efficient ibuprofen delivery from anhydrous semisolid formulation based on a novel cross-linked silicone polymer network: an in vitro and in vivo study.
Aliyar H; Huber R; Loubert G; Schalau G
J Pharm Sci; 2014 Jul; 103(7):2005-2011. PubMed ID: 24797876
[TBL] [Abstract][Full Text] [Related]
51. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation.
Li S; Wang X; Wang Y; Zhao Q; Zhang L; Yang X; Liu D; Pan W
Drug Dev Ind Pharm; 2015; 41(12):2089-99. PubMed ID: 26304493
[TBL] [Abstract][Full Text] [Related]
52. Design and evaluation of ocusert for controlled delivery of flurbiprofen sodium.
Kulhari H; Pooja D; Narayan H; Meena L; Prajapati SK
Curr Eye Res; 2011 May; 36(5):436-41. PubMed ID: 21501077
[TBL] [Abstract][Full Text] [Related]
53. Physicochemical, in vitro and in vivo evaluation of flurbiprofen microemulsion.
Naeem M; Ur Rahman N; Tavares GD; Barbosa SF; Chacra NB; Löbenberg R; Sarfraz MK
An Acad Bras Cienc; 2015 Sep; 87(3):1823-31. PubMed ID: 26375019
[TBL] [Abstract][Full Text] [Related]
54. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
[TBL] [Abstract][Full Text] [Related]
55. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
Int J Pharm; 2010 Mar; 388(1-2):64-72. PubMed ID: 20035851
[TBL] [Abstract][Full Text] [Related]
56. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study.
Morsi NM; Aboelwafa AA; Dawoud MHS
J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602
[TBL] [Abstract][Full Text] [Related]
57. Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition.
Jacob S; Nair AB; Al-Dhubiab BE
J Liposome Res; 2017 Dec; 27(4):283-292. PubMed ID: 27558522
[TBL] [Abstract][Full Text] [Related]
58. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Abdelbary AA; AbouGhaly MH
Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
[TBL] [Abstract][Full Text] [Related]
59. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
60. A modern approach for controlled transdermal delivery of diflunisal: optimization and in vivo evaluation.
Sallam MA; Motawaa AM; Mortada SM
Drug Dev Ind Pharm; 2013 Apr; 39(4):600-10. PubMed ID: 22697341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
